Treatment of Malignant Melanoma

Video

Treatment of Malignant Melanoma

  • A 46-year-old Caucasian female presented one year ago with deep ulcerated primary tumor and multiple involved lymph nodes.
  • She was diagnosed with stage IIIC melanoma.
  • Patient underwent wide local incision and compete lymph node dissection and appeared to be clear of disease.
  • Patient decided not to pursue adjuvant therapy after surgery.
  • Six months after surgery, she developed abdominal pain.
  • Imaging showed multiple masses in the liver, > 1 cm, scattered pulmonary nodules and some enlarged lymph nodes.
  • Tumor biopsy confirmed melanoma and mutational analysis showed BRAF V600E mutation.
  • The patient is started on dabrafenib 150 mg bid and trametinib 2 mg qd.
Related Videos
Video 2 - "Setting Expectations + First-Line and Second-Line Treatment of Graft Versus Host Disease"
Video 1 - "Patient Case: Pathology of Graft Versus Host Disease"
Gary J. Schiller, MD, an expert on MDS
Gary J. Schiller, MD, an expert on MDS
Gary J. Schiller, MD, an expert on MDS
Gary J. Schiller, MD, an expert on MDS
Gary J. Schiller, MD, an expert on MDS
Gary J. Schiller, MD, an expert on MDS
Related Content
Global Phase 3 Trial Investigates mRNA Vaccine for Melanoma Treatment

Global Phase 3 Trial Investigates mRNA Vaccine for Melanoma Treatment

April 11th 2024
Article

Jeff Yorio, MD, discussed the unmet needs among patients with melanoma and plans for a phase 3 study assessing an mRNA vaccine.

Read More

Understanding and Treating Mucosal Melanoma

Understanding and Treating Mucosal Melanoma

April 14th 2023
Podcast

In season 4, episode 4 of Targeted Talks, Richard D. Carvajal, MD, discusses mucosal melanoma and treatment options for the disease.

Listen

Lifileucel Shows Long-Term Efficacy in Melanoma

Lifileucel Shows Long-Term Efficacy in Melanoma

March 18th 2024
Article

In patients with advanced melanoma, lifileucel showed durable efficacy and a 4-year overall survival rate of 21.9%, according to long-term findings from the phase 2 C-144-01 trial.

Read More

A Look Inside the Toolbox for BRAF-Mutant Metastatic Melanoma

A Look Inside the Toolbox for BRAF-Mutant Metastatic Melanoma

February 15th 2022
Podcast

In season 3, episode 1 of Targeted Talks, Michael A. Postow, MD, discusses available targeted agents for BRAF-mutant melanoma and ongoing clinical questions about treating the disease.

Listen

Dosing and Regimen Changes Promote Tolerability in Advanced Melanoma

Dosing and Regimen Changes Promote Tolerability in Advanced Melanoma

March 14th 2024
Article

During a Targeted Oncology™ Case-Based Roundtable™ event, Michael B. Atkins, MD, discussed dosing considerations and toxicity when choosing combination treatment for patients with melanoma. This is the second of 2 articles based on this event.

Read More

AHN Launches Cutting-Edge Melanoma and Skin Cancer Center

AHN Launches Cutting-Edge Melanoma and Skin Cancer Center

March 14th 2024
Article

In an interview with Targeted Oncology, Howard D. Edington, MD, discussed Allegheny Health Network’s recently unveiled Melanoma and Skin Cancer Center and its new technology.

Read More